Xingsheng H. Hu
Beijing, 100029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 118 publications
Progress in targeted therapy for chronic thromboembolic pulmonary hypertension
Journal: Zhonghua yi xue za zhi
Published: May 14, 2026
Efficacy and Safety of Firmonertinib Plus Anlotinib as First-Line Treatment for Advanced NSCLC With EGFR Mutations: A Single-Arm, Phase I/II Trial.
Journal: Clinical lung cancer
Published: August 15, 2025
Chlorine-coordinated iron single-atom nanozymes for amplified ferroptosis in triple-negative breast cancer therapy.
Journal: Journal of nanobiotechnology
Published: July 19, 2025
Efficacy and Safety of Afatinib Plus Bevacizumab as First-Line Treatment for Advanced NSCLC Patients With Epidermal Growth Factor Receptor (EGFR) Mutations: A Multicenter, Phase II Trial.
Journal: Thoracic cancer
Published: June 09, 2025
Pemetrexed plus platinum outperforms other platinum-based adjuvant chemotherapy regimens for resected stage II-IIIA lung adenocarcinoma: an open-label, historical-control study.
Journal: Journal of thoracic disease
Published: May 23, 2025
Association between dietary behavior and type 2 diabetes in the older adults aged 65 years and over in 18 longevity areas of China
Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
Published: May 15, 2025
Prevention of ileostomy-related complications and management of anal preservation surgery for rectal cancer
Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
Published: April 24, 2025
Development of a nomogram for predicting pathological complete response after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer
Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
Published: March 24, 2025
Immune checkpoint inhibitors combined with anti-angiogenic therapy as second- or further-line treatment for small cell lung cancer: Efficacy, safety, and prognostic biomarkers.
Journal: International journal of cancer
Published: February 25, 2025
Clinical, immune cell, and genetic features predicting survival and long-term response to first-line chemo-immunotherapy treatment for non-small cell lung cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: December 27, 2024
Lactate production by tumor-resident Staphylococcus promotes metastatic colonization in lung adenocarcinoma.
Journal: Cell host & microbe
Published: November 10, 2024
Concurrent EGFR L858R and K860I mutations: PCR-negative but NGS-positive alterations that respond to EGFR inhibitors in non-small cell lung cancer.
Journal: Journal of thoracic disease
Published: October 20, 2024
Last Updated: 09/26/2026